AzTrials
AzTrials

Airway ManagementNCT05647174

MGPOCUS Assisted Bronchoscopy in Difficult Endotracheal Intubation

A study testing MGPOCUS-assisted bronchoscope-guided intubation and Bronchoscope-guided intubation in people with Airway Management, run by Peking Union Medical College Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Introduction Endoracheal intubation (ETI) is a crucial but risky procedure, especially among patients with suspected difficult endotracheal intubation (DTI). Bronchoscopy, as an improved technique commonly used in DTI, might encounters the difficulties of visualization. Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Airway Management
What is being tested?
MGPOCUS-assisted bronchoscope-guided intubation and Bronchoscope-guided intubation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
350 participants
Where
1 siteChina
Study dates
1 Aug 2023to 1 Mar 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged between 18 and 85 years old.
  • Requiring ETI.
  • Anticipated DTI meets one or more positive findings in the airway evaluation, including history, examination, and appropriate investigations of anatomy .
  • Signed written informed consent.
  • Willingness for the primary anesthesia team to participate.

Who cannot join

  • Anterior neck lesions (masses, lacerations, or subcutaneous emphysema).
  • A history of neck operation or tracheotomy.
  • Allergies to ultrasound coupling gel.
  • At risk of pulmonary or cardiovascular complications during intubation with flexible bronchoscope, including severe hypoxemia, severe pulmonary hypertension, unstable or severe obstructive airway disease.
  • At risk of bleeding during bronchoscope, including anticoagulants or coagulopathy, renal insufficiency, and superior vena cava syndrome.
  • High risk of aspiration.
  • Current pregnancy.
  • Patient unable to cooperate (for awake intubation).

Trial locations and contacts

1 site in 1 country.

China1 site
  • Peing Union Medical College Hospital

    Beijing, 100730

Other trials in China

About this study

Official title: Developing a Magnetic-POCUS-assisted Bronchoscopy in Difficult Endotracheal Intubation

Introduction Endoracheal intubation (ETI) is a crucial but risky procedure, especially among patients with suspected difficult endotracheal intubation (DTI). Bronchoscopy, as an improved technique commonly used in DTI, might encounters the difficulties of visualization. The magnetic point-of-care ultrasound (MGPOCUS) not only provide an novel visualization from outside, but also enable the estimation of relative position and trajectory of bronchoscopy. The study aims to evaluate the efficiency of MGPOCUS assisted bronchoscopy in time taken to the first-attempt success, the first-attempt and overall success of ETI, complications and satisfaction of visualization among patients suspected with DTI.

Methods and analysis The current study is a randomized, parallel-group, single-blinded, single-center study. Participants (n=350) will be recruited by primary anesthesiologist and randomized to groups of ETI with bronchoscopy or MGPOCUS assisted bronchoscopy. The primary outcome is time taken to the first-attempt success ETI. Secondary outcomes include procedure time, the first-attempt and overall success, complications and satisfaction of visualization. Cox regression with the Bonferroni correction and the linear mixed regression will be used to analysis the outcomes.

Being tested
MGPOCUS-assisted bronchoscope-guided intubation, Bronchoscope-guided intubation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MGPOCUS-assisted bronchoscope-guided intubationProcedure or surgery

    Application of ultrasound instruments that can detect magnetic signals to determine the position of the magnetised bronchoscopy to guide the direction of its advancement and thus optimise difficult endotracheal intubation.

  • Bronchoscope-guided intubationProcedure or surgery

    Routine bronchoscope- guided intubation.

Study groups in NCT05647174
Study groupRoleWhat they receive
MGPOCUS-assisted bronchoscope-guided intubationActive comparatorNot described
Receives: Procedure: MGPOCUS-assisted bronchoscope-guided intubation
Bronchoscope-guided IntubationExperimentalNot described
Receives: Procedure: Bronchoscope-guided intubation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to success

    Time taken in seconds to successful intubation at the first-attempt

    Measured: At once after performing intubation at the first attempt and confirming successful endotracheal intubation by capnography

Secondary outcomes (6)
  1. Procedure time

    Accumulation of every attempts (no more than 2) from bronchoscope passage of teeth to tube well placed.

    Measured: Whiler performing intubation.

  2. The first-attempt success

    Intubation at the first attempt is whether successful or failure, confirmed by capnography.

    Measured: At once after the first-attempt and confirmed by capnography..

  3. Overall success

    Intubation is whether successful or failure within no more than 2 attempts and no more than 600 seconds, confirmed by capnography.

    Measured: At once after procedure and confirmed by capnography.

  4. Number of attempts

    Number of attempts to fulfill intubation

    Measured: While performing the procedure

  5. Satisfaction with visualizaiton

    Satisfaction with visualization estimated by performers.

    Measured: At once after every attempt before confirmed by capnography

  6. Intubation relative complications

    Including desaturation (<90%), obvious trauma ,bloody secretions, post-extuvation hoarseness and sore throat.

    Measured: At once after performing procedure and after extubation.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Dec 2022
  2. Study start1 Aug 2023 (estimated)
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion1 Mar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
350 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05647174
Sponsor's protocol ID
MGPOCUS-DTI
Status last verified
Mar 2023
First submitted
3 Dec 2022
Last updated
4 Apr 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Data is available upon request from the corresponding author after the completion of the study.

Publications

  • Tian Y, Fei Y, Bai B, Cui X, Zhang Y, Wang C, Yu C, Huang Y. Developing a magnetic POCUS-guided bronchoscope for patients with suspected difficult endotracheal intubation in a general tertiary hospital: protocol for a randomised controlled study. BMJ Open. 2023 Jun 27;13(6):e071325. doi: 10.1136/bmjopen-2022-071325.

    PubMed 37369409

Questions about this trial

What is this clinical trial studying?

A study testing MGPOCUS-assisted bronchoscope-guided intubation and Bronchoscope-guided intubation in people with Airway Management, run by Peking Union Medical College Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to success (time frame: At once after performing intubation at the first attempt and confirming successful endotracheal intubation by capnography). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05647174, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in